1. Biotech company 2seventy bio is cutting 176 positions — equivalent to 40 percent of its workforce.
2. Absci, a company using generative artificial intelligence in the drug discovery process, laid off 30 employees or about 15 percent of its staff.
3. Biogen will cut about 1,000 jobs as it plans to save $700 million by 2025.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
